These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18615330)

  • 1. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.
    Marioni G; Staffieri C; Staffieri A; De Filippis C; Blandamura S
    Acta Otolaryngol; 2009 May; 129(5):476-80. PubMed ID: 18615330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
    Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
    Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
    Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
    Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
    Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
    Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
    Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological functions of maspin.
    Bailey CM; Khalkhali-Ellis Z; Seftor EA; Hendrix MJ
    J Cell Physiol; 2006 Dec; 209(3):617-24. PubMed ID: 17001697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases.
    Marioni G; Staffieri A; Bertolin A; Giacomelli L; D'Alessandro E; Ottaviano G; Accordi D; Stramare R; de Filippis C; Blandamura S
    Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1103-10. PubMed ID: 20052590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma.
    Marioni G; D'Alessandro E; Giacomelli L; De Filippis C; Calgaro N; Sari M; Staffieri A; Blandamura S
    Anticancer Res; 2006; 26(6C):4927-32. PubMed ID: 17214364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?
    Marioni G; Giacomelli L; D'Alessandro E; Marchese-Ragona R; Staffieri C; Ferraro SM; Staffieri A; Blandamura S
    Am J Otolaryngol; 2008; 29(3):156-62. PubMed ID: 18439947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear expression of onco-suppressors nm23-H1 and maspin are associated with lower recurrence rate in laryngeal carcinoma.
    Marioni G; Ottaviano G; de Filippis C; Fasanaro E; Randon B; Meneghesso S; Giacomelli L; Astolfi L; Blandamura S
    Am J Otolaryngol; 2019; 40(2):224-229. PubMed ID: 30683471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of maspin's subcellular localization in invasive ductal breast cancer via light microscopy and computerized image analysis: a comparative study.
    Panou M; Kavantzas N; Sergentanis T; Sakellariou S; Agrogiannis G; Chatzipantelis P; Anastasopoulou E; Soranoglou V; Zagouri F; Korkolopoulou P; Patsouris E; Bramis I; Zografos GC
    J BUON; 2013; 18(2):342-51. PubMed ID: 23818344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear MASPIN expression relates to a better prognosis in elderly patients with laryngeal carcinoma.
    Marioni G; Blandamura S; Lionello M; Giacomelli L; Staffieri C; Fasanaro E; Manzato E; Staffieri A
    Acta Otolaryngol; 2011 Nov; 131(11):1220-5. PubMed ID: 21732742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.
    Marioni G; D'Alessandro E; Bertolin A; Staffieri A
    Acta Otolaryngol; 2010; 130(1):4-9. PubMed ID: 19322702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis.
    Maass N; Hojo T; Rösel F; Ikeda T; Jonat W; Nagasaki K
    Clin Biochem; 2001 Jun; 34(4):303-7. PubMed ID: 11440731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
    Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
    Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
    Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin expression and anti-apoptotic pathway regulation by bcl2 in laryngeal cancer.
    Lovato A; Franz L; Carraro V; Bandolin L; Contro G; Ottaviano G; de Filippis C; Blandamura S; Alessandrini L; Marioni G
    Ann Diagn Pathol; 2020 Apr; 45():151471. PubMed ID: 31986422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
    Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.
    Xia W; Lau YK; Hu MC; Li L; Johnston DA; Sheng Sj; El-Naggar A; Hung MC
    Oncogene; 2000 May; 19(20):2398-403. PubMed ID: 10828881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.